Timothy G. Youngquist 2020 Irrevocable Trust
Position in MLYS — Mineralys Therapeutics, Inc.
CIK 2109159
Position in MLYS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,721,445
New position
Shares Held
100,869
first reported quarter
Ownership
0.114%
of shares outstanding
% of Portfolio
1.63%
of 13F equity value
Holder Rank
#84
of 224 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Timothy G. Youngquist 2020 Irrevocable Trust holds $46,702,441 across 5 Biotechnology names. MLYS ranks #4 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CHRS |
Coherus Oncology, Inc.
|
13,050,623 | $18,270,872 | |
| 2 | RLAY |
Relay Therapeutics, Inc.
|
801,464 | $14,995,391 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
|
271,849 | $10,604,829 | |
| 4 | MLYS |
Mineralys Therapeutics, Inc.
This page
|
100,869 | $2,721,445 | |
| 5 | CNTX |
Context Therapeutics Inc.
|
198,384 | $109,904 |
All Filings in MLYS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,721,445 | 100,869 | Shares | Sole | 2026-08-07 | |
| No filing history on record for this holder in this stock. | ||||||